Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Roberto Pili

Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial

The Lancet

Medicine

2016

English

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer

English

Pharmacological Polyamine Catabolism Upregulation With Methionine Salvage Pathway Inhibition as an Effective Prostate Cancer Therapy

Nature Communications

English

Phase 1 Trials of Anti-Enpp3 Antibody Drug Conjugates in Advanced Refractory Renal Cell Carcinomas

Clinical Cancer Research

Cancer Research

Oncology

2018

English

Mp49-02 a Study to Evaluate the Prognostic and Predictive Utility of CCP and HRD Assays and Genetic Sequencing in Patients Undergoing Neoadjuvant Chemotherapy in Bladder Cancer

Journal of Urology

Urology

2016

English

Combinatorial Antitumor Effect of HDAC and the PI3K-Akt-mTOR Pathway Inhibition in a Pten Defecient Model of Prostate Cancer

Oncotarget

Oncology

2013

English

Preservation of Truncal Genomic Alterations in Clear Cell and Papillary Renal Cell Carcinomas With Sarcomatoid Features: An Intra- And Intertumoral, Multifocal Fluorescence in Situ Hybridization Analysis Reveals Limited Genetic Heterogeneity

Molecular Carcinogenesis

Cancer Research

Molecular Biology

2017

English

A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer

Clinical Genitourinary Cancer

Oncology

Urology

2013

English

Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Clinical Genitourinary Cancer

Oncology

Urology

2017

English

Metastatic Small Cell Carcinoma of the Prostate in an Octogenarian With Significant Response to First-Line Chemotherapy

Hematology & Medical Oncology

2017

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Roberto Pili

Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer

Pharmacological Polyamine Catabolism Upregulation With Methionine Salvage Pathway Inhibition as an Effective Prostate Cancer Therapy

Phase 1 Trials of Anti-Enpp3 Antibody Drug Conjugates in Advanced Refractory Renal Cell Carcinomas

Mp49-02 a Study to Evaluate the Prognostic and Predictive Utility of CCP and HRD Assays and Genetic Sequencing in Patients Undergoing Neoadjuvant Chemotherapy in Bladder Cancer

Combinatorial Antitumor Effect of HDAC and the PI3K-Akt-mTOR Pathway Inhibition in a Pten Defecient Model of Prostate Cancer

Preservation of Truncal Genomic Alterations in Clear Cell and Papillary Renal Cell Carcinomas With Sarcomatoid Features: An Intra- And Intertumoral, Multifocal Fluorescence in Situ Hybridization Analysis Reveals Limited Genetic Heterogeneity

A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer

Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Metastatic Small Cell Carcinoma of the Prostate in an Octogenarian With Significant Response to First-Line Chemotherapy